## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-15T23:30:00.910Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Eye Test & Vision Checker" developer_entity: "Mobimartech SARL" bundle_id: "com.mni.vision.check.pro" app_store_id: "6621183937" google_play_id: "com.b2creativedesigns.eyetest" category: "Productivity" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-03-22" report_date: "2026-05-15" last_verified: "2026-05-15" report_version: "3.7" total_reviews: 11829 overall_rating: 4.06 sentiment: "Mixed" sentiment_score: 55 confidence: "medium" confidence_score: 0.7 top_praise_theme: "Convenience of home testing" top_complaint_theme: "Aggressive subscription pricing" top_request_theme: "Clinical validation" review_sample_size: 62 data_age_days: 0 momentum_velocity: "zombie" intelligence_version: 3 nemesis: "Vision Check by Optikos Prime" competitor_count: 8 tags: ["productivity", "subscription", "mixed sentiment", "mobile app", "app review", "app analysis", "individuals", "seeking", "home-based"] canonical_url: "https://marlvel.ai/intel-report/productivity/eye-test-vision-checker" license: "CC-BY-NC 4.0" content_version: "v2" --- # Eye Test & Vision Checker App Audit ## TL;DR {#tldr} - **Category**: Productivity · Subscription - **Signal**: Rating 4.06 · Sentiment Mixed - **Recent focus**: Aggressive subscription pricing (top complaint) · Convenience of home testing (top praise) · Clinical validation (top request) > **TL;DR:** Eye Test & Vision Checker is a productivity app by Mobimartech SARL, rated 4.06/5 by 11.8K users, with Mixed user sentiment (55/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Eye Test & Vision Checker shows Mixed sentiment (4.06/5 from 11.8K reviews) — users praise convenience of home testing but report issues with aggressive subscription pricing. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.06/5 (11.8K reviews) | | **User Mood** | Mixed | | **Category** | Productivity | | **Developer** | Mobimartech SARL | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.7/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Mobimartech SARL - **Category:** Productivity - **Target Audience:** Individuals seeking home-based vision monitoring and those interested in eye strain reduction exercises. - **Platforms:** iOS & Android - **Version Audited:** 3.7 - **Audit Date:** 2026-05-15 - **Signal Count:** 62 reviews analyzed - **Confidence:** Medium (0.7/1.0) - **App Store ID (iOS):** 6621183937 - **Bundle ID:** com.mni.vision.check.pro - **Google Play ID:** com.b2creativedesigns.eyetest - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-05-15 ## Executive Snapshot **What it is:** Eye Test & Vision Checker is a diagnostic and vision-improvement app for iOS and Android that provides home-based eye exams and eye-strain exercises. **Why users hire it:** Users hire the app for immediate, low-cost insights into their visual acuity without the friction of scheduling professional appointments, so the app must balance diagnostic accessibility with clinical trust to retain users. ## App DNA (Features & Intent) - **[Standard] Visual Acuity Testing:** Digital Snellen-style charts to measure eyesight clarity - **[Standard] Color Blindness Assessment:** Ishihara-based color perception test - **[Differentiator] Vision Improvement Exercises:** Guided techniques for relaxation and focus * *User Intent:* Users need clear guidance to understand and adopt the product quickly. ## Market Position {#market-position} The app maintains a 3.77 average rating across 11,829 total ratings, signaling a stable but polarized user base. The subscription-only model creates a revenue ceiling that prevents wider adoption among casual users who prefer freemium alternatives. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Pro Access - Weekly ($6.99), Pro Access - Monthly ($29.99), Pro Access - Yearly ($59.99) - **Analysis:** Subscription-only model anchored at $6.99 weekly, utilizing high-frequency pricing to capture users seeking immediate diagnostic results. ## 🟡 User Sentiment (Medium Confidence: 11.8K reviews) {#user-sentiment} - **Overall Rating:** 4.06/5 - **Platform Split:** iOS 3.5/5 (33 ratings) | Android 4.1/5 (11.8K ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Convenience of home testing** ### Top Complaints (Impact Areas) - **Aggressive subscription pricing** ### Top Requests (What Users Want) - **Clinical validation** ## SWOT Analysis {#swot} **Core Strengths:** - Broad accessibility of diagnostic tools - Historical tracking creates longitudinal data moat **Critical Frictions:** - $6.99 weekly price exceeds category median - Lack of clinical validation limits trust **Growth Levers:** - B2B partnerships with optical retailers - Integration with wearable health data **Market Threats:** - Optician-gated rivals eroding professional-grade segment - Tightening health-tech regulations on diagnostic claims ## Recent Changes (v2 → v3) {#recent-changes} The app shows a slight rating improvement but remains constrained by a high-friction subscription model and increasing pressure from clinically-validated competitors. **Overall trend**: Mixed **Compared at**: 2026-05-15 ### High-impact changes - **[Shifted] Primary Complaint Evolution** (sentiment) — Top complaint shifted from 'AI-generated test pattern distortions' to 'Aggressive subscription pricing'. - **[Shifted] SWOT Weakness Update** (swot) — Weakness updated from 'AI-generated test patterns' to '$6.99 weekly price exceeds category median' and 'Lack of clinical validation'. ### Medium-impact changes - **[Improved] Rating Increase** (sentiment) — Average user rating improved from 3.48 to 3.77. - **[Shifted] Competitive Stance** (positioning) — Executive summary shifted from focusing on 'AI-generated test pattern' quality issues to 'clinical gating' and 'wellness tool' positioning. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Eye Test & Vision Checker vs Vision Check by Optikos Prime — Head to Head - **[Vision Check by Optikos Prime](https://marlvel.ai/intel-report/health-fitness/vision-check-by-optikos-prime)** by OptikosPrime ApS: This app directly competes by offering professional-grade vision screening tools that mirror the target's core value proposition of remote eye health monitoring. - **Key differences:** - Provides optician-gated testing protocols that offer higher clinical credibility than standard consumer-facing vision apps. - Focuses on precision measurement tools that cater to users seeking medical-grade accuracy over general wellness checks. - Leverages a remote screening model that effectively bridges the gap between home testing and professional care. - **Where Eye Test & Vision Checker wins:** - ✅ Offers a broader, more accessible suite of tests for casual users without requiring professional gating. - ✅ Maintains a significantly larger user base and historical data footprint across Android and iOS platforms. - **Where Vision Check by Optikos Prime wins:** - ❌ Delivers higher perceived clinical authority through optician-gated testing and precision-focused measurement features. - ❌ Maintains a modern, updated interface that signals higher trust for health-conscious users. - **Verdict:** The target must pivot toward clinical validation or partnerships to prevent losing the 'serious' user segment to Optikos Prime. ### Contenders (Strong Challengers) - **[Color Blindness Test Ishihara](https://marlvel.ai/intel-report/medical/color-blindness-test-ishihara)** by Rina Katrina: This app competes for the same vision-conscious user base by specializing in specific diagnostic testing that the target app also covers. - Specializes exclusively in the Ishihara method, providing a deeper diagnostic experience for color vision deficiencies. - Includes a professional screening mode that provides structured reports suitable for sharing with eye care providers. ### Peers (What They Do Better) - **[GaborPatchGame](https://marlvel.ai/intel-report/health-fitness/gaborpatchgame)** by SHUUICHI WATANABE: This app targets the vision health market through gamified visual therapy rather than diagnostic testing. - Uses gamification to improve visual acuity, offering a more engaging retention model than static diagnostic tests. - Features multiple difficulty levels and game modes that encourage daily habit formation for vision improvement. - **[Molekule](https://marlvel.ai/intel-report/health-fitness/molekule)** by MOLEKULE GROUP, INC.: While focused on air quality, it competes for the same 'home health' wallet share and user attention as the target app. - Builds a strong moat through proprietary PECO technology and a recurring filter subscription revenue model. - Integrates air quality sensing with a high-end hardware ecosystem that creates significant user lock-in. - **[Eye Chart Pro Remote Control](https://marlvel.ai/intel-report/medical/eye-chart-pro-remote-control)** by Dok LLC: This app serves the same clinical utility space by providing tools for eye chart management and remote testing environments. - Offers specialized remote control functionality that allows practitioners to manage testing environments from a distance. - Utilizes a cross-app integration strategy to unlock advanced features, creating a modular ecosystem for eye care. - **[EyeQue PDCheck](https://marlvel.ai/intel-report/health-fitness/eyeque-pdcheck)** by EyeQue Corporation: This app occupies the same vision-health niche by focusing on specific biometric measurements like pupillary distance for eyewear users. - Focuses on hardware-adjacent utility by helping users obtain precise pupillary distance measurements for online glasses shopping. - Provides long-term vision tracking services that encourage recurring app usage for monitoring prescription changes. ### New Kids on the Block (What's Innovative) - **[GotCGM](https://marlvel.ai/intel-report/health-fitness/gotcgm)** by Gluroo Imaginations Inc.: A newcomer in the health-tech space leveraging deep Apple ecosystem integration to capture health-conscious users. - Utilizes advanced Apple ecosystem features like Live Activities and CarPlay to provide constant, low-friction health monitoring. - **[vision.app](https://marlvel.ai/intel-report/health-fitness/vision-app)** by Capital Certainty SL: A new entrant focusing on professional data integration and web-based demos to capture the vision screening market. - Prioritizes professional data integration to allow seamless sharing of vision test results with clinical providers. ## What's New - **Latest (v2.6.11, 2 years ago):** Technical update: upgraded library version. ## App Momentum (Zombie) {#momentum} - Updated iOS build in March 2026 - Maintains consistent diagnostic feature set > **Cadence:** 2 total versions · 0 majors in last 6 months · 54 days since last update · 942 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Eye Test & Vision Checker is an established productivity app that is available. With a 4.06/5 rating from 11.8K reviews, it shows polarized user reception. > **Bottom Line:** The app captures casual users through accessible home-testing tools, but the aggressive subscription pricing limits long-term retention, so the PM should pivot to a freemium model to capture a larger user base before competitors with better clinical authority dominate. **Best for:** Individuals seeking home-based vision monitoring and those interested in eye strain reduction exercises. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Pivot to freemium model because current $6.99/week pricing causes high churn → increase top-of-funnel conversion — *User complaints highlight the weekly price as a primary barrier to entry.* _(trade-off: deprioritize Pause the development of new vision exercises — pricing friction has a higher impact on revenue.)_ - [ ] [MAINTAIN] [MEDIUM IMPACT] Audit diagnostic disclaimers because health-tech regulations are tightening → reduce legal risk — *Competitor analysis shows professional-grade rivals are gaining ground through clinical credibility.* _(trade-off: deprioritize Same-quarter capacity available — no major lever displaced.)_ ### Feature Gaps vs Competitors - Optician-gated testing protocols (available in Vision Check by Optikos Prime but absent here) ### Outlook: Stable The home-health market is consolidating around apps that offer either high-end clinical credibility or low-friction free utility. Eye Test & Vision Checker is currently stuck in the middle, so revenue growth depends on either adding professional-grade validation or lowering the entry barrier to scale the user base. - ⚪ The latest update focused on stability, signaling a shift toward maintenance rather than aggressive feature expansion. - 🔴 High-frequency pricing complaints in reviews suggest the current subscription model is reaching a conversion ceiling. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.06/5 | | Total Reviews | 11.8K | | Sentiment | Mixed (55/100) | | Confidence | Medium | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Eye Test & Vision Checker** (this app) | 4.06/5 | Mixed | Mobimartech SARL | | [GotCGM](https://marlvel.ai/intel-report/health-fitness/gotcgm) | 3.9/5 | N/A | Gluroo Imaginations Inc. | | [GaborPatchGame](https://marlvel.ai/intel-report/health-fitness/gaborpatchgame) | 4.8/5 | N/A | SHUUICHI WATANABE | | [Color Blindness Test Ishihara](https://marlvel.ai/intel-report/medical/color-blindness-test-ishihara) | 3.0/5 | N/A | Rina Katrina | | [Molekule](https://marlvel.ai/intel-report/health-fitness/molekule) | 4.4/5 | N/A | MOLEKULE GROUP, INC. | | [Vision Check by Optikos Prime](https://marlvel.ai/intel-report/health-fitness/vision-check-by-optikos-prime) | 5.0/5 | N/A | OptikosPrime ApS | ## Company Profile - **Developer:** Mobimartech SARL - **Website:** [https://eyeshealthtest.com/](https://eyeshealthtest.com/) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/eye-test-vision-checker/id6621183937?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.b2creativedesigns.eyetest&hl=en&gl=us) - **Dev Site:** [Official Website](https://eyeshealthtest.com/) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*GotCGM*](https://marlvel.ai/intel-report/health-fitness/gotcgm) (Gluroo Imaginations Inc.) — 3.9/5 Rating | N/A Sentiment - [*GaborPatchGame*](https://marlvel.ai/intel-report/health-fitness/gaborpatchgame) (SHUUICHI WATANABE) — 4.8/5 Rating | N/A Sentiment - [*Color Blindness Test Ishihara*](https://marlvel.ai/intel-report/medical/color-blindness-test-ishihara) (Rina Katrina) — 3.0/5 Rating | N/A Sentiment - [*Molekule*](https://marlvel.ai/intel-report/health-fitness/molekule) (MOLEKULE GROUP, INC.) — 4.4/5 Rating | N/A Sentiment - [*Vision Check by Optikos Prime*](https://marlvel.ai/intel-report/health-fitness/vision-check-by-optikos-prime) (OptikosPrime ApS) — 5.0/5 Rating | N/A Sentiment - [*EyeQue PDCheck*](https://marlvel.ai/intel-report/health-fitness/eyeque-pdcheck) (EyeQue Corporation) — 3.7/5 Rating | Mixed Sentiment - [*vision.app*](https://marlvel.ai/intel-report/health-fitness/vision-app) (Capital Certainty SL) — N/A Rating | N/A Sentiment - [*Eye Chart Pro Remote Control*](https://marlvel.ai/intel-report/medical/eye-chart-pro-remote-control) (Dok LLC) — 3.0/5 Rating | Mixed Sentiment - [*Mitsu: AI Life Coach*](https://marlvel.ai/intel-report/productivity/mitsu-ai-life-coach) (C2 Insights) — N/A Rating | N/A Sentiment - [*Pattrn - Discipline Tracker*](https://marlvel.ai/intel-report/productivity/pattrn-discipline-tracker) (Pedro Schott) — 4.8/5 Rating | Positive Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 62 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/productivity/eye-test-vision-checker) Data licensed for AI Agent attribution under CC-BY-NC 4.0.